BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29260338)

  • 21. Intratumoral pseudoaneurysm within a liver metastasis of gastric cancer: a case report.
    Ohara H; Ishibashi Y; Yoshimura S; Yamazaki R; Hatao F; Koshiishi T; Morita Y; Imamura K
    Surg Case Rep; 2020 Feb; 6(1):39. PubMed ID: 32072324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer.
    Hayase S; Yamada L; Ujiie D; Nirei A; Tada T; Hanayama H; Monma T; Saze Z; Ohki S; Kono K
    Fukushima J Med Sci; 2019; 65(1):6-12. PubMed ID: 30996218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
    Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed esophageal anastomotic complication and ramucirumab therapy: A case report.
    Roth RH; Malfitano MJ; Reilley M; Martin LW
    Thorac Cancer; 2023 Oct; 14(29):2976-2980. PubMed ID: 37667428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer.
    Khan U; Shah MA
    Expert Opin Biol Ther; 2019 Nov; 19(11):1135-1141. PubMed ID: 31452409
    [No Abstract]   [Full Text] [Related]  

  • 26. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
    Seo S; Suzuki T; Misumi T; Tashiro H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Case of Advanced Gastric Cancer with Long-Term Survival Due to Successful Ramucirumab and Paclitaxel Therapy].
    Ono Y; Aoyama T; Morita J; Maezawa Y; Amano S; Sawazaki S; Numata M; Tamagawa H; Sato T; Oshima T; Yoshikawa T; Ozawa Y; Yukawa N; Masuda M; Rino Y
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2156-2158. PubMed ID: 30692316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perforation of intramural gastric metastasis during preoperative chemotherapy in a patient with thoracic esophageal squamous cell carcinoma.
    Okumura T; Shimada Y; Hojo S; Sekine S; Hirano K; Moriyama M; Miwa S; Nagata T; Tsukada K
    Int J Surg Case Rep; 2015; 17():23-7. PubMed ID: 26519812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of Paclitaxel + Ramucirumab Combination Therapy for Advanced Gastric Cancer Progressing After First-line Chemotherapy in Japan.
    Saito S; Muneoka Y; Ishikawa T; Akazawa K
    Clin Ther; 2017 Dec; 39(12):2380-2388. PubMed ID: 29175097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A Case Report of Inoperable Gastric Cancer with Peritoneal Dissemination, Liver Metastasis, and Lung Metastasis Successfully Treated with Weekly Paclitaxel and Ramucirumab].
    Takahashi S; Hanaka J; Takahashi M; Goya T
    Gan To Kagaku Ryoho; 2019 Jun; 46(6):1065-1067. PubMed ID: 31273177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
    Arakawa Y; Tamura M; Aiba K; Morikawa K; Aizawa D; Ikegami M; Yuda M; Nishikawa K
    Oncol Lett; 2017 Sep; 14(3):3039-3042. PubMed ID: 28928842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of Ramucirumab Therapy for Advanced Gastric Cancer after Stent Placement for Esophagogastric Junction Carcinoma Obstruction-A Case Report].
    Takeuchi T; Yuasa Y; Okitsu H; Maki H; Tsuneki T; Matsuo Y; Edagawa H; Mori O; Miyamoto N; Eto S; Fujiwara S; Tomibayashi A; Ishikura H
    Gan To Kagaku Ryoho; 2019 Jun; 46(6):1057-1059. PubMed ID: 31273175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Büyükkaramikli NC; Blommestein HM; Riemsma R; Armstrong N; Clay FJ; Ross J; Worthy G; Severens J; Kleijnen J; Al MJ
    Pharmacoeconomics; 2017 Dec; 35(12):1211-1221. PubMed ID: 28656543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare Presentation of Small Bowel Perforation Secondary to Microscopic Metastasis of Non-small Cell Lung Cancer (NSCLC): A Case Report.
    Alhusari L; Abdallah M; Al-Madani A; Nwanwene K; Lawrence LM; Pacioles T
    Cureus; 2023 Dec; 15(12):e50383. PubMed ID: 38213343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small bowel perforation due to indistinguishable metastasis of angiosarcoma: case report and brief literature review.
    Uchihara T; Imamura Y; Iwagami S; Kajihara I; Kanemaru H; Karashima R; Ida S; Ishimoto T; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Iyama K; Ihn H; Baba H
    Surg Case Rep; 2016 Dec; 2(1):42. PubMed ID: 27156097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy.
    Larkins E; Scepura B; Blumenthal GM; Bloomquist E; Tang S; Biable M; Kluetz P; Keegan P; Pazdur R
    Oncologist; 2015 Nov; 20(11):1320-5. PubMed ID: 26446239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.
    Smyth EC; Tarazona N; Chau I
    Immunotherapy; 2014; 6(11):1177-86. PubMed ID: 25496333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer.
    Bando H; Shimodaira H; Fujitani K; Takashima A; Yamaguchi K; Nakayama N; Takahashi T; Oki E; Azuma M; Nishina T; Hironaka S; Komatsu Y; Shitara K
    Eur J Cancer; 2018 Mar; 91():86-91. PubMed ID: 29353164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.
    Wang Z; Zhang J; Zhang L; Liu P; Xie Y; Zhou Q
    J Chemother; 2016 Aug; 28(4):328-34. PubMed ID: 26099278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ramucirumab: A Review in Advanced Gastric Cancer.
    Greig SL; Keating GM
    BioDrugs; 2015 Oct; 29(5):341-51. PubMed ID: 26341713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.